Eugenia Oviedo-Joekes

Academic Rank(s)

Professor PhD, Tier 1 Canada Research Chair

Phone

604 822 2772

Email

eugenia@cheos.ubc.ca

Location

2206 East Mall Vancouver, BC V6T 1Z3

About
OpenClose

I obtained a degree in clinical psychology at the University of Cordoba (Argentina), a PhD in social psychology and behavioural sciences methodology in Spain, and completed post-doctoral studies at the Andalusian School of Public Health. There, I conducted research on substance use and public health, and was part of a clinical trial testing pharmaceutical-grade heroin for opioid use disorder.

I moved to Canada in 2006 to join Dr. Schechter’s research program and became an Investigator on the NAOMI study, North America’s first heroin-assisted treatment trial. I have led the SALOME study, testing injectable hydromorphone for opioid use disorder, and provided evidence to expand injectable opioid agonist treatment across Canada.

Website

Awards
OpenClose

Tier 1 Canada Research Chair in Person-Centered Care in Addiction and Public Health

Providence Health Care Research and Mission Award (2016)

Faculty of Medicine Distinguished Achievement Awards: Excellence in Clinical or Applied Research (2016)

CIHR New Investigator Award (2013)

Professional Affiliations
OpenClose

Editorial Board, BMC Public Health

Scientist, Centre for Advancing Health Outcomes

Research
OpenClose

PubMed

ResearchGate

Dr. Oviedo-Joekes’s main research area is public health and substance use, with a focus on innovative treatments for opioid use disorder for people that are not reached by the health care system by optimizing the uptake and effectiveness of these treatments using a person-center approach.

She is currently part of several Canadian Institutes of Health Research-funded grants; formerly co-investigator of North America’s first heroin-assisted treatment trial, the North American Opiate Medication Initiative (NAOMI); and formerly the principal investigator of the Study to Assess Long-Term Opioid Maintenance Effectiveness (SALOME), a randomized clinical trial that tested innovative treatments for severe, long-term opioid dependency. She is also the principal investigator of the GeMa (Gender Matters) study, which evaluates gender patterns of drug use, access to care, and health among long-term opioid users; a co-investigator of The Cedar Project, a cohort of young Aboriginal people using drugs; and the principal investigator of the Program of Outcomes Research on Treatment with Injectables for Addiction (PORTIA).

Teaching
OpenClose

SPPH 550 – Public Health Approaches to Substance Use and Addictions